Abstract

Background: The microRNA let-7a contains three copies of genes and is associated with various types of cancer, including gastric cancer. In this study, we aim to investigate the differential expression patterns of microRNA let7a in PBMCs from patients of gastric cancer (GC) before and after neoadjuvant chemotherapy.
Methods: The differential expression levels of let-7a were detected in PBMCs from 22 patients with GC before and after neoadjuvant chemotherapy by reverse transcription quantitative polymerase chain reaction (RT-qPCR). The statistical analysis was performed with t-test and one-way AVOVA.
Results: MicroRNA let-7a level was significantly decreased in patients with GC after neoadjuvant chemotherapy (p < 0.05). In patients with GC, microRNA let-7a has different expression patterns with different neoadjuvant chemotherapy cycles.
Conclusions: Our study demonstrated that microRNA let-7a was expressed differentially in patients with GC before and after neoadjuvant chemotherapy. These data supported that microRNA let-7a may have a potential role in efficacy assessment in patients with GC with neoadjuvant chemotherapy.

DOI: 10.7754/Clin.Lab.2017.171213